3-Bromopyruvate induces necrotic cell death in sensitive melanoma cell lines

Biochemical and Biophysical Research Communications

Volumn 396, Issue 2, 2010, Pages 495-500

  Qin, J Z ^a   Xin, H ^a   Nickoloff, B J ^a  

^a LOYOLA UNIVERSITY   (United States)

Author keywords

3 Bromopyruvate; ATP; Glutathione; Melanoma; Metabolomics; Superoxide anion

Indexed keywords

ACETYLCYSTEINE; ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENT; BROMOPYRUVIC ACID; CASPASE; GLUTATHIONE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; UNCLASSIFIED DRUG;

ARTICLE; CANCER RESISTANCE; CELL DEATH; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; MELANOMA CELL; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL;

ACETYLCYSTEINE; ADENOSINE TRIPHOSPHATE; APOPTOSIS; CELL LINE, TUMOR; GLUTATHIONE; HUMANS; MELANOMA; MEMBRANE POTENTIAL, MITOCHONDRIAL; NECROSIS; PYRUVATES; SKIN NEOPLASMS; SUPEROXIDES;

EID: 77952745676     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.04.126     Document Type: Article

References (30)

1. Miller A.J., and Mihm Jr. M.C. Melanoma. N. Engl. J. Med. 355 (2006) 51-65
2. Pollock P.M., Harper U.L., Hansen K.S., Yudt L.M., Stark M., Robbins C.M., Moses T.Y., Hostetter G., Wagner U., Kakareka J., Salem G., Pohida T., Heenan P., Duray P., Kallioniemi O., Hayward N.K., Trent J.M., and Meltzer P.S. High frequency of BRAF mutations in nevi. Nat. Genet. 33 (2003) 19-20
3. Palmieri G., Capone M., Ascierto M.L., Gentilcore G., Stroncek D.F., Casula M., Sini M.C., Palla M., Mozzillo N., and Ascierto P.A. Main roads to melanoma. J. Transl. Med. 7 (2009) 86
4. Akcali C., Zincirkeser S., Erbagcy Z., Akcali A., Halac M., Durak G., Sager S., and Sahin E. Detection of metastases in patients with cutaneous melanoma using FDG-PET/CT. J. Int. Med. Res. 35 (2007) 547-553
5. Mathupala S.P., Ko Y.H., and Pedersen P.L. Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy. Semin. Cancer Biol. 19 (2009) 17-24
6. Shaw R.J. Glucose metabolism and cancer. Curr. Opin. Cell Biol. 18 (2006) 598-608
7. Plas D.R., and Thompson C.B. Cell metabolism in the regulation of programmed cell death. Trends Endocrinol. Metab. 13 (2002) 75-78
8. Xu R.H., Pelicano H., Zhou Y., Carew J.S., Feng L., Bhalla K.N., Keating M.J., and Huang P. Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res. 65 (2005) 613-621
9. Kroemer G., and Pouyssegur J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 13 (2008) 472-482
10. DeBerardinis R.J., Sayed N., Ditsworth D., and Thompson C.B. Brick by brick: metabolism and tumor cell growth. Curr. Opin. Genet. Dev. 18 (2008) 54-61
11. Hsu P.P., and Sabatini D.M. Cancer cell metabolism: Warburg and beyond. Cell 134 (2008) 703-707
12. Vander Heiden M.G., Cantley L.C., and Thompson C.B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324 (2009) 1029-1033
13. Ko Y.H., Smith B.L., Wang Y., Pomper M.G., Rini D.A., Torbenson M.S., Hullihen J., and Pedersen P.L. Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP. Biochem. Biophys. Res. Commun. 324 (2004) 269-275
14. Ihrlund L.S., Hernlund E., Khan O., and Shoshan M.C. 3-Bromopyruvate as inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs. Mol. Oncol. 2 (2008) 94-101
15. Liu X.H., Zheng X.F., and Wang Y.L. Inhibitive effect of 3-bromopyruvic acid on human breast cancer MCF-7 cells involves cell cycle arrest and apoptotic induction. Chin. Med. J. (Engl.) 122 (2009) 1681-1685
16. Nickoloff B.J., Hendrix M.J.C., Pollock P.M., Trent J.M., Miele L., and Qin J.Z. Notch and NOXA-related pathways in melanoma cells. J. Invest. Dermatol. Symp. Proc. 10 (2005) 95-104
17. Han Y.H., Kim S.H., Kim S.Z., and Park W.H. Caspase inhibitor decreases apoptosis in pyrogallol-treated lung cancer Calu-6 cells via the prevention of GSH depletion. Int. J. Oncol. 33 (2008) 1099-1105
18. Jayaraman S. Flow cytometric determination of mitochondrial membrane potential changes during apoptosis of T lymphocytic and pancreatic beta cell lines: comparison of tetramethylrhodamineethylester (TMRE), chloromethyl-X-rosamine (H2-CMX-Ros) and MitoTracker Red 580 (MTR580). J. Immunol. Methods 306 (2005) 68-79
19. Han Y.H., Kim S.H., Kim S.Z., and Park W.H. Intracellular GSH levels rather than ROS levels are tightly related to AMA-induced HeLa cell death. Chem. Biol. Interact. 171 (2008) 67-78
20. Madesh M., and Hajnoczky G. VDAC-dependent permeabilization of the outer mitochondrial membrane by superoxide induces rapid and massive cytochrome c release. J. Cell Biol. 155 (2001) 1003-1015
21. Schafer F.Q., and Buettner G.R. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic. Biol. Med. 30 (2001) 1191-1212
22. Pedersen P.L. The cancer cell's "power plants" as promising therapeutic targets: an overview. J. Bioenerg. Biomembr. 39 (2007) 1-12
23. Armstrong J.S. Mitochondria: a target for cancer therapy. Br. J. Pharmacol. 147 (2005) 239-248
24. Curtin J.A., Fridlyand J., Kageshita T., Patel H.N., Busam K.J., Kutzner H., Cho K.H., Aiba S., Brocker E.B., LeBoit P.E., Pinkel D., and Bastian B.C. Distinct sets of genetic alterations in melanoma. N. Engl. J. Med. 353 (2005) 2135-2147
25. Tsujimoto Y., and Shimizu S. Role of the mitochondrial membrane permeability transition in cell death. Apoptosis 12 (2007) 835-840
26. Fleury C., Mignotte B., and Vayssiere J.L. Mitochondrial reactive oxygen species in cell death signaling. Biochimie 84 (2002) 131-141
27. Le Bras M., Clement M.V., Pervaiz S., and Brenner C. Reactive oxygen species and the mitochondrial signaling pathway of cell death. Histol. Histopathol. 20 (2005) 205-219
28. Estrela J.M., Ortega A., and Obrador E. Glutathione in cancer biology and therapy. Crit. Rev. Clin. Lab. Sci. 43 (2006) 143-181
29. Kim J.S., Ahn K.J., Kim J.A., Kim H.M., Lee J.D., Lee J.M., Kim S.J., and Park J.H. Role of reactive oxygen species-mediated mitochondrial dysregulation in 3-bromopyruvate induced cell death in hepatoma cells: ROS-mediated cell death by 3-BrPA. J. Bioenerg. Biomembr. 40 (2008) 607-618
30. Pereira da Silva A.P., El Bacha T., Kyaw N., dos Santos R.S., da Silva W.S., Almeida F.C., Da Poian A.T., and Galina A. Inhibition of energy-producing pathways of HepG2 cells by 3-bromopyruvate. Biochem. J. 417 (2009) 717-726